Mariposa is developing innovative solutions to treat keratin related skin disorders. The company is a spin out from Neem Biotech, based in Wales, which has a long history in pharmaceutical research and has extensive capabilities to develop commercially viable solutions for serious healthcare challenges.
About Mariposa
Developing novel treatments for patients with keratin related skin disorders
The Science
Grounded on specialist expertise in epithelial cell biology and keratin intermediate filaments
Collaborate with us
Join in to innovate with us and to find new treatments for patients with no current cures
Damian Marron is an experienced Board Chair and Non-Executive Director, corporate advisor and former serial CEO with a successful track record of value creation through public and venture capital financing, portfolio planning, M&A, licensing agreements and R&D collaborations, both as...
